...previously eligible for a $750,000 payment upon FDA clearance. Echo Therapeutics Inc. (NASDAQ:ECTE), Philadelphia, Pa. Ferndale Pharma Group Inc....

...a dermatology-focused sales team to promote Eletone and other dermatology products. Details were not disclosed. Ferndale Pharma Group Inc....

...sales of about £600,000 ($934,501). Terms were not disclosed. Alliance Pharma plc (LSE:APH), Chippenham, U.K. Ferndale Pharma Group Inc....

...in gross profit from its Microcyn products business for the fiscal year ending March 31. Ferndale Pharma Group Inc....

...to Echo from Ferndale (see BioCentury, June 8, 2009). Echo Therapeutics Inc. (OTCBB:ECTE), Franklin, Mass. Ferndale Pharma Group Inc....

...market the product in North America and the U.K. Echo Therapeutics Inc. (OTCBB:ECTE), Franklin, Mass. Ferndale Pharma Group Inc....

...eligible for escalating royalties after the minimum is reached. Echo Therapeutics Inc. (OTCBB:ECTE), Franklin, Mass. Ferndale Pharma Group Inc....

...for milestones and double-digit royalties. Further terms were not disclosed (see BioCentury, Nov. 12, 2007). Ferndale Pharma Group Inc....

...has an option to further develop and commercialize the product. Further terms were not disclosed. Ferndale Pharma Group Inc....

...to treat mild to moderate atopic dermatitis in patients 3 months of age and older. Ferndale Laboratories Inc....